38 related articles for article (PubMed ID: 19844989)
1. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.
Advani AS; McDonough S; Coutre S; Wood B; Radich J; Mims M; O'Donnell M; Elkins S; Becker M; Othus M; Appelbaum FR
Br J Haematol; 2014 May; 165(4):504-9. PubMed ID: 24579885
[TBL] [Abstract][Full Text] [Related]
2. Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Kim TK; Xu ML; Podoltsev NA; Prebet T; Barbarotta L; Amin K; Kasberg S; Roche K; Stahl M; Gore SD; Zeidan AM
Ann Hematol; 2016 Oct; 95(11):1895-8. PubMed ID: 27468851
[No Abstract] [Full Text] [Related]
3. Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities.
Rogers JH; Gupta R; Reyes JM; Gundry MC; Medrano G; Guzman A; Aguilar R; Conneely SE; Song T; Johnson C; Barnes S; Cristobal CDD; Kurtz K; Brunetti L; Goodell MA; Rau RE
Blood Adv; 2021 Oct; 5(19):3876-3890. PubMed ID: 34492683
[TBL] [Abstract][Full Text] [Related]
4. Novel targets for treatment of adult acute lymphocytic leukemia.
Kasner MT
Curr Hematol Malig Rep; 2010 Oct; 5(4):207-12. PubMed ID: 20680526
[TBL] [Abstract][Full Text] [Related]
5. Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT.
Swords R; Hayden PJ; Molloy K; Lawlor M; Browne PV; Murphy PT
Eur J Haematol; 2004 Dec; 73(6):450-1. PubMed ID: 15522070
[No Abstract] [Full Text] [Related]
6. Infusion of anti-CD10 monoclonal antibody (J5) following ablative chemotherapy in a patient with refractory pre-B acute lymphoblastic leukemia.
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Presno-Bernal M; Alvarez-Amaya C
Rev Invest Clin; 1991; 43(3):259-63. PubMed ID: 1840161
[TBL] [Abstract][Full Text] [Related]
7. Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series.
Grigoleit GU; Kapp M; Tan SM; Unzicker C; Einsele H; Mielke S; Topp MS; Stuhler G
Leuk Lymphoma; 2009 Dec; 50(12):2071-4. PubMed ID: 19886845
[No Abstract] [Full Text] [Related]
8. Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.
Papayannidis C; Derenzini E; Iacobucci I; Curti A; Paolini S; Cilloni D; Baccarani M; Martinelli G
Am J Hematol; 2009 Dec; 84(12):849-50. PubMed ID: 19844989
[No Abstract] [Full Text] [Related]
9. The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
McGregor BA; Brown AW; Osswald MB; Savona MR
Am J Hematol; 2009 Apr; 84(4):228-30. PubMed ID: 19260120
[TBL] [Abstract][Full Text] [Related]
10. [Plasmacytoid dendritic cell tumor].
Pérez-Crespo M; Moragón M; Onrubia J; Sevila A; Alfonso R; Miralles J; Requena L
Actas Dermosifiliogr; 2011 Apr; 102(3):229-31. PubMed ID: 21232729
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
